Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.96 |
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.96 |
| ▸ | HPGD | P15428 | 7/20 | 0.96 |
| ▸ | HSD17B10 | Q99714 | 7/20 | 0.96 |
| ▸ | CA9 | Q16790 | 7/20 | 0.96 |
| ▸ | GAA | P10253 | 6/20 | 0.96 |
| ▸ | GLA | P06280 | 5/20 | 0.96 |
| ▸ | CA12 | O43570 | 5/20 | 0.96 |
| ▸ | CA1 | P00915 | 5/20 | 0.96 |
| ▸ | CASP1 | P29466 | 4/20 | 0.96 |
| ▸ | CASP7 | P55210 | 4/20 | 0.96 |
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.62 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.62 |
| ▸ | MAOB | P27338 | 1/20 | 0.62 |
| ▸ | KDR | P35968 | 1/20 | 0.62 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL30457821 | 1.00 | ALDH1A1 (0.96) | ALDH1A1KDM4EHPGDHSD17B10CA9 | |
| Bromide SCHEMBL28878217 | 0.98 | ALDH1A1 (0.93) | ALDH1A1KDM4EHPGDHSD17B10CA9 | |
| SCHEMBL29645144 | 0.98 | ALDH1A1 (1.00) | ALDH1A1KDM4EHPGDHSD17B10CA9 | |
| SCHEMBL28806970 | 0.98 | ALDH1A1 (1.00) | ALDH1A1KDM4EHPGDHSD17B10CA9 | |
| SCHEMBL37677 | 0.98 | ALDH1A1 (1.00) | ALDH1A1KDM4EHPGDHSD17B10CA9 | |
| Hydrochloric Acid SCHEMBL2545954 | 0.96 | ALDH1A1 (0.96) | ALDH1A1KDM4EHPGDHSD17B10CA9 | |
| Hydrochloric Acid SCHEMBL567469 | 0.96 | ALDH1A1 (0.96) | ALDH1A1KDM4EHPGDHSD17B10CA9 | |
| SCHEMBL1037558 | 0.96 | ALDH1A1 (0.96) | ALDH1A1KDM4EHPGDHSD17B10CA9 | |
| Hydrochloric Acid SCHEMBL30762676 | 0.96 | ALDH1A1 (0.96) | ALDH1A1KDM4EHPGDHSD17B10CA9 | |
| Acetic Acid SCHEMBL3998167 | 0.90 | ALDH1A1 (0.84) | ALDH1A1KDM4EHPGDHSD17B10CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10807971-B2 | Pyrrolidinone compounds | ELI LILLY AND COMPANY (US) | 2020-10-20 | — | — | US | disclosed |
| US-20190345144-A1 | PYRROLIDINONE COMPOUNDS | ELI LILLY AND COMPANY | 2019-11-14 | — | — | US | disclosed |
| WO-2018098781-A1 | PYRROLIDINONE COMPOUNDS | ELI LILLY AND COMPANY (US) | 2018-06-07 | — | — | WO | disclosed |
| WO-2018102256-A1 | PYRROLIDINONE COMPOUNDS | ELI LILLY AND COMPANY (US) | 2018-06-07 | — | — | WO | disclosed |
| EP-3259266-A1 | PYRAZOLE COMPOUNDS | Eli Lilly and Company (US) | 2017-12-27 | — | — | EP | disclosed |
| US-20170334885-A1 | PYRAZOLE COMPOUNDS | ELI LILLY AND COMPANY | 2017-11-23 | — | — | US | disclosed |
| US-9822101-B1 | Pyrazole compounds | ELI LILLY AND COMPANY (US) | 2017-11-21 | — | — | US | disclosed |
| WO-2017005069-A1 | PYRROLIDINONE COMPOUNDS | ELI LILLY AND COMPANY (US) | 2017-01-12 | — | — | WO | disclosed |
| WO-2017004797-A1 | PYRROLIDINONE COMPOUNDS | ELI LILLY AND COMPANY (US) | 2017-01-12 | — | — | WO | disclosed |
| WO-2016133770-A1 | PYRAZOLE COMPOUNDS | ELI LILLY AND COMPANY (US) | 2016-08-25 | — | — | WO | disclosed |
| WO-2016131198-A1 | PYRAZOLE COMPOUNDS | ELI LILLY AND COMPANY (US) | 2016-08-25 | — | — | WO | disclosed |
| WO-2016131914-A1 | A POLYMER BLEND FOR A TIRE | TRINSEO EUROPE GMBH (CH) | 2016-08-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190345144-A1 | PYRROLIDINONE COMPOUNDS | NPY4R, NPY2R, NPY5R | ALDH1A1 1579/4885KDM4E 177/4885HPGD 595/4885 |
| US-10807971-B2 | Pyrrolidinone compounds | NPY4R, NPY2R, NPY5R | ALDH1A1 1579/4885KDM4E 177/4885HPGD 595/4885 |
| US-20170334885-A1 | PYRAZOLE COMPOUNDS | METAP2, DPP7, DPP4 | ALDH1A1 3746/4885KDM4E 566/4885HPGD 4548/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.